Login

Alexandre Fraichard, CEO, Genoway 00:00:00

Share On Facebook Share On Twitter

Interview of Alexandre Fraichard, CEO of Genoway

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Jennifer Boyle Discusses High-Grade Gold Discoveries at Tartan Lake Mine
00:10:00
High-Purity Manganese Sulfate Monohydrate for North American EV Sector
00:10:00
Metallic Minerals: Advancing High-Grade Silver Projects in the Yukon
00:10:00
Benchmark Metals: Driving Gold and Silver Exploration in Northern British Columbia - Insights from Jim at the One-to-One Conference in New York
00:10:00
Meeting with Kim Chang-ho, CEO of Korea's leading motion control company, AJINXTECH | Kim Chang-ho, CEO, AjinExTek Co LtdA059120:KOE
00:10:00
Aerojet Rocketdyne is celebrating significant advancements, including securing its largest RL10 engine contract from United Launch Alliance and L3Harris's acquisition of the company, enhancing its propulsion and defense capabilities. Concurrently, Jeep CE
00:10:00
Sales Director Incubator: Leeson Brook, GWA Group Ltd. | Urs Meyerhans - Managing Director and Chief Executive Officer of GWA Group
00:10:00
Craig Taylor Discusses Defense Metals' Strategic Position in the Global Critical Metals Market
00:10:00
Galway Metals' Gold and Zinc Exploration Projects in Canada
00:10:00
Greenland Minerals: Advancing the World's Most Significant Emerging Rare Earth Project
00:10:00
Matthew Continetti Reflects on 9/11's Impact and American Conservatism|Matthew Continetti,Professor, American Enterprise Institute
00:10:00
Focused on technologies that extend the boundaries of human performance|Andrew Firlik,Managing Partner,Jazz Venture Partners

© 2026 Nehu